Hims & Hers Health, Inc.HIMSNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +95.09% | +110.67% | +72.61% | +49.16% | +28.41% |
| Gross Profit Growth | +81.10% | +88.00% | +62.19% | +39.06% | -6.30% |
| EBITDA Growth | +991.98% | +412.81% | +153.45% | +11.72% | +47.81% |
| Operating Income Growth | +0.00% | +484.64% | +142.28% | -47.23% | -32.04% |
| Net Income Growth | +1990.36% | +344.69% | +219.66% | -79.13% | -20.84% |
| EPS Growth | +1933.90% | +340.00% | +206.45% | -80.00% | -25.00% |
| EPS Diluted Growth | +1764.41% | +300.00% | +200.35% | -80.19% | -27.27% |
| Weighted Average Shares Growth | +4.43% | +4.00% | +4.55% | +4.49% | +3.67% |
| Weighted Average Shares Diluted Growth | +14.77% | +7.52% | +9.36% | +5.79% | +3.06% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +292.96% | +322.21% | -135.67% | +74.42% | -25.10% |
| Free Cash Flow Growth | +451.69% | +321.31% | -245.96% | +15.16% | -98.62% |
| Receivables Growth | -9.90% | +8.42% | +21.33% | +803.61% | +428.77% |
| Inventory Growth | +186.80% | +155.13% | +249.36% | +115.82% | +79.64% |
| Asset Growth | +60.37% | +99.00% | +290.76% | +270.82% | +204.54% |
| Book Value per Share Growth | +32.69% | +53.31% | +48.70% | +26.35% | +9.46% |
| Debt Growth | +14.04% | +436.11% | +9001.42% | +9743.48% | +11039.33% |
| R&D Expense Growth | +77.17% | +95.21% | +102.89% | +92.38% | +72.48% |
| SG&A Expenses Growth | +70.09% | +69.48% | +53.73% | +37.87% | +8.75% |